Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

Shanghai Stock Exchange 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow Yield on January 14, 2025: 5.92%

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. Free Cash Flow Yield is 5.92% on January 14, 2025, a 6.38% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 52-week high Free Cash Flow Yield is 8.11% on February 05, 2024, which is 37.00% above the current Free Cash Flow Yield.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 52-week low Free Cash Flow Yield is 4.48% on October 29, 2024, which is -24.25% below the current Free Cash Flow Yield.
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 6.27%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shanghai Stock Exchange: 600613.SS

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.

CEO	Mr. Feng Bin
IPO Date	Aug. 20, 1992
Location	China
Headquarters	Changfa Tower
Employees	1,426
Sector	Health Care
Industries Pharmaceuticals

Description

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, tonic products, cold and cough, children's medicine, and anti-fungal drugs. Its products include prescription drugs and OTC products. The company was founded in 1992 and is based in Shanghai, China.

Key trends

Past 5 years